01.10.2009 | Original Article
Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China
Erschienen in: Journal of Infection and Chemotherapy | Ausgabe 5/2009
Einloggen, um Zugang zu erhalten